Table A2.

Patients with identified pathogens analysed according to the existence of MDR.

MDR	Value (Nr., %/Mean ± SD/Median (IQR))		p
	Absent (n = 26)	Present (n = 22)
Age	57.35 ± 16.34	63.36 ± 16.26	0.209 *
Gender (male)	13 (50%)	8 (36.4%)	0.393 **
Septic shock	7 (26.9%)	9 (40.9%)	0.366 **
WBC	15,400 (13,230–18,290)	15,640 (13,630–19,940)	0.456 ***
CRP	93.5 (76–176.75)	135.5 (86.75–215.5)	0.264 ***
Procalcitonin	2.67 (0.75–6.32)	3.28 (1.76–9.23)	0.301 ***
ASA grading
I	1 (3.8%)	1 (4.5%)	0.170 **
II	18 (69.2%)	8 (36.4%)
III	3 (11.5%)	7 (31.8%)
IV	3 (11.5%)	4 (18.2%)
V	1 (3.8%)	2 (9.1%)
Comorbidities	10 (38.5%)	12 (54.5%)	0.384 **
Cardiovascular disease	10 (38.5%)	12 (54.5%)	0.384 **
Diabetes mellitus	0 (0%)	1 (4.5%)	0.458 **
Hinchey class
IIA	3 (11.5%)	4 (18.2%)	0.042 **
IIB	16 (61.5%)	5 (22.7%)
III	6 (23.1%)	9 (40.9%)
IV	1 (3.8%)	4 (18.2%)
Source control
Laparoscopic drainage	11 (42.3%)	5 (22.7%)	0.157 **
Laparoscopic resection + anastomosis	5 (19.2%)	4 (18.2%)
Laparoscopic Hartmann’s procedure	1 (3.8%)	5 (22.7%)
Open resection + anastomosis	2 (7.7%)	0 (0%)
Open Hartmann’s procedure	7 (26.9%)	8 (36.4%)
Multiple pathogens	4 (15.4%)	8 (36.4%)	0.111 **
ICU admission > 1 day	8 (3.8%)	11 (50%)	0.239 **
Length of stay
<7 days	8 (30.8%)	7 (31.8%)	0.348 **
7–10 days	15 (57.7%)	9 (40.9%)
>10 days	3 (11.5%)	6 (27.3%)
Adequate empiric AB therapy	25 (96.2%)	11 (50%)	<0.001 **
Mortality	1 (3.8%)	2 (9.1%)	0.587 **

* Student T-Test, ** Fisher’s Exact Test, *** Mann–Whitney U Test.